These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2782920)
1. [Pharmacokinetics of cisplatin and vindesine in a patient with chronic renal failure undergoing hemodialysis]. Ayabe H; Uchikawa T; Kimino K; Tagawa Y; Kawahara K; Tomita M Gan To Kagaku Ryoho; 1989 Sep; 16(9):3283-5. PubMed ID: 2782920 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy]. Tokunaga J; Kikukawa H; Nishi K; Kitani K; Fujii J; Honda J; Wada Y; Ueda S; Nakano M Gan To Kagaku Ryoho; 2000 Nov; 27(13):2079-85. PubMed ID: 11103239 [TBL] [Abstract][Full Text] [Related]
3. [Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis]. Ono S; Miyazaki T; Nishikawa K; Watanabe K; Hisanaga S Gan To Kagaku Ryoho; 1992 Jan; 19(1):115-8. PubMed ID: 1309629 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of cis-dichlorodiammine platinum (II) in patients undergoing hemodialysis]. Miyakawa M; Sugimoto K; Ohe Y; Masuoka H; Miyahara T Gan To Kagaku Ryoho; 1987 Aug; 14(8):2491-5. PubMed ID: 3619461 [TBL] [Abstract][Full Text] [Related]
5. [Combined 5-FU and CDDP in a gastric cancer patient undergoing hemodialysis--pharmacokinetics of 5-FU and CDDP]. Cho H; Imada T; Masudo K; Doi C; Inaba M; Tokunaga M; Takanashi Y Gan To Kagaku Ryoho; 2000 Nov; 27(13):2135-8. PubMed ID: 11103248 [TBL] [Abstract][Full Text] [Related]
6. [Study on changes in plasma platinum concentrations after administration of CDDP to maintenance hemodialysis patients]. Suwata J; Hiraga S; Hida M; Takamiya T; Iida T; Sato T Gan To Kagaku Ryoho; 1988 Feb; 15(2):243-8. PubMed ID: 3341786 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of cisplatin in long-term hemodialysis treatment]. Sturn W; Sanwald R; Ehninger G Dtsch Med Wochenschr; 1989 Mar; 114(9):337-9. PubMed ID: 2920679 [TBL] [Abstract][Full Text] [Related]
8. [M-VAC therapy in a patient with ureteral carcinoma accompanied by chronic renal failure]. Yokogi H; Yamasaki Y; Ishibe T Gan To Kagaku Ryoho; 1993 Dec; 20(15):2405-7. PubMed ID: 8259861 [TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy for an esophageal cancer patient undergoing continuous ambulatory peritoneal dialysis for chronic renal failure and measurement of plasma concentration of the drug]. Okuyama M; Motoyama S; Maruyama K; Ohta H; Tsuchiya N; Oyake J; Ogawa J Gan To Kagaku Ryoho; 2005 Jul; 32(7):1029-32. PubMed ID: 16044967 [TBL] [Abstract][Full Text] [Related]
10. [48-hour continuous infusion of vindesine (followed by cisplatin) in advanced lung cancer. Chronopharmacokinetic data and clinical efficacy]. Focan C; Doalto L; Mazy V; Levi F; Bruguerolle B; Cano JP; Rahmani R; Hecquet B Bull Cancer; 1989; 76(8):909-12. PubMed ID: 2620124 [No Abstract] [Full Text] [Related]
11. [Chemotherapy with nedaplatin for an oral floor cancer patient undergoing chronic hemodialysis]. Iwasaki A; Tanizaki A; Ohbayashi Y; Miyake M; Nagahata S; Takahashi N Gan To Kagaku Ryoho; 2000 Dec; 27(14):2231-4. PubMed ID: 11142167 [TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of vindesine infusion. Rahmani R; Kleisbauer JP; Cano JP; Martin M; Barbet J Cancer Treat Rep; 1985; 69(7-8):839-44. PubMed ID: 2410121 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin]. Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700 [TBL] [Abstract][Full Text] [Related]
14. [Plasma concentration of 4'-epi-adriamycin in hemodialysis patients]. Tomoe H; Nishino S; Koyama I; Uda M; Toma H Gan To Kagaku Ryoho; 1992 Apr; 19(4):549-51. PubMed ID: 1558406 [No Abstract] [Full Text] [Related]
15. [Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis]. Nishioka Y; Kitada O; Meguro T; Aragane K; Tanimukai T; Nakamura H; Nakahama H; Matsuyama T; Sugita M; Yano T; Takenaka Y; Takamitsu Y Gan To Kagaku Ryoho; 1999 Mar; 26(4):527-30. PubMed ID: 10097751 [TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
18. Optimization of cisplatin doses in a testicular cancer patient with acute renal failure. Pouliquen AL; Bousquet G; Le Maignan C; Bauer C; Lejri N; Misset JL; Lokiec F J Oncol Pharm Pract; 2011 Sep; 17(3):265-9. PubMed ID: 19933251 [TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report]. Yanagawa H; Takishita Y; Bando H; Shinohara T; Tanaka H; Sumitani H Gan To Kagaku Ryoho; 1993 Dec; 20(15):2409-11. PubMed ID: 8259862 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects. Hohnloser JH; Schierl R; Hasford B; Emmerich B Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]